FAM216B
gene geneOn this page
Also known as FLJ40919
Summary
FAM216B (family with sequence similarity 216 member B, HGNC:26883) is a protein-coding gene on chromosome 13q14.11, encoding Protein FAM216B (Q8N7L0).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_001318932
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26883 |
| Approved symbol | FAM216B |
| Name | family with sequence similarity 216 member B |
| Location | 13q14.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40919 |
| Ensembl gene | ENSG00000179813 |
| Ensembl biotype | protein_coding |
| Entrez | 144809 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000313851, ENST00000537894
RefSeq mRNA: 2 — MANE Select: NM_001318932
NM_001318932, NM_182508
CCDS: CCDS9386
Canonical transcript exons
ENST00000313851 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001271628 | 42786763 | 42786883 |
| ENSE00001271636 | 42781584 | 42781664 |
| ENSE00001271655 | 42784054 | 42784166 |
| ENSE00003753164 | 42788591 | 42791549 |
Expression profiles
Bgee: expression breadth broad, 86 present calls, max score 98.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.7965 / max 317.3730, expressed in 99 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 134888 | 0.4041 | 69 |
| 134887 | 0.2666 | 70 |
| 134886 | 0.1258 | 39 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 98.89 | gold quality |
| bronchus | UBERON:0002185 | 97.51 | gold quality |
| right uterine tube | UBERON:0001302 | 97.09 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 95.05 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 93.09 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 88.14 | gold quality |
| nasopharynx | UBERON:0001728 | 88.12 | gold quality |
| oviduct epithelium | UBERON:0004804 | 84.74 | gold quality |
| fallopian tube | UBERON:0003889 | 83.48 | gold quality |
| right atrium auricular region | UBERON:0006631 | 77.58 | gold quality |
| cardiac atrium | UBERON:0002081 | 77.25 | gold quality |
| right lung | UBERON:0002167 | 75.30 | gold quality |
| caput epididymis | UBERON:0004358 | 73.96 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 73.30 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 72.01 | gold quality |
| trachea | UBERON:0003126 | 67.90 | gold quality |
| endometrium | UBERON:0001295 | 67.47 | gold quality |
| lymph node | UBERON:0000029 | 63.54 | gold quality |
| left uterine tube | UBERON:0001303 | 61.72 | gold quality |
| vermiform appendix | UBERON:0001154 | 60.78 | gold quality |
| lung | UBERON:0002048 | 59.82 | gold quality |
| lower lobe of lung | UBERON:0008949 | 57.35 | silver quality |
| caecum | UBERON:0001153 | 56.27 | gold quality |
| heart | UBERON:0000948 | 55.17 | gold quality |
| rectum | UBERON:0001052 | 53.75 | gold quality |
| upper lobe of lung | UBERON:0008948 | 53.25 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 53.05 | gold quality |
| corpus callosum | UBERON:0002336 | 52.12 | gold quality |
| cerebellar vermis | UBERON:0004720 | 51.65 | gold quality |
| tonsil | UBERON:0002372 | 51.20 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 62.34 |
| E-MTAB-10287 | yes | 26.65 |
| E-HCAD-1 | yes | 25.75 |
| E-GEOD-130148 | yes | 12.09 |
| E-ANND-3 | yes | 11.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
105 targeting FAM216B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-10523-5P | 99.91 | 69.22 | 2038 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-4271 | 99.88 | 68.32 | 2244 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
Literature-anchored findings (GeneRIF, showing 1)
- Meta-analysis of Transcriptomic Data from Lung Autopsy and Cellular Models of SARS-CoV-2 Infection. (PMID:37486510)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam216b | ENSMUSG00000045655 |
| rattus_norvegicus | Fam216b | ENSRNOG00000021943 |
Paralogs (1): FAM216A (ENSG00000204856)
Protein
Protein identifiers
Protein FAM216B — Q8N7L0 (reviewed: Q8N7L0)
All UniProt accessions (1): Q8N7L0
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the FAM216 family.
RefSeq proteins (2): NP_001305861, NP_872314 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029373 | FAM216 | Family |
Pfam: PF15107
UniProt features (2 total): chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7L0-F1 | 77.16 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 55 (showing top):
AAAYRNCTG_UNKNOWN, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, chr13q14, SPZ1_01, DODD_NASOPHARYNGEAL_CARCINOMA_DN, ZNF486_TARGET_GENES, MIR8485, MIR3662, MIR4795_3P, MIR95_5P, MIR7159_5P, MIR448, MIR4762_3P, MIR580_5P, MIR670_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
400 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM216B | LINC03043 | A4D0Y5 | 584 |
| FAM216B | ANKUB1 | A6NFN9 | 536 |
| FAM216B | TSPAN19 | P0C672 | 514 |
| FAM216B | LRRC71 | Q8N4P6 | 490 |
| FAM216B | DNAJC15 | Q9Y5T4 | 478 |
| FAM216B | ANKRD66 | B4E2M5 | 469 |
| FAM216B | MORN5 | Q5VZ52 | 461 |
| FAM216B | OVCH1 | Q7RTY7 | 449 |
| FAM216B | DYNLT5 | Q8N7M0 | 430 |
| FAM216B | AKAP11 | Q9UKA4 | 419 |
| FAM216B | FAM216A | Q8WUB2 | 418 |
| FAM216B | TMEM212 | A6NML5 | 414 |
| FAM216B | HOXA3 | O43365 | 411 |
| FAM216B | ST8SIA6 | P61647 | 402 |
| FAM216B | SNTN | A6NMZ2 | 395 |
IntAct
0 interactions, top by confidence:
BioGRID (1): FAM216B (Synthetic Lethality)
ESM2 similar proteins: A1JU78, A3KMU5, B3DZB3, B3LT59, B3WDM3, B8Y7Y5, C5DFL1, C7GQR4, C8ZD61, C9JBD0, O20173, O34800, O74416, O83451, O97179, P03045, P08346, P0C2N4, P10185, P10260, P10302, P19810, P30637, P34743, P35940, P36353, P39607, P42430, P61416, Q03A13, Q06616, Q0P641, Q11109, Q12393, Q24475, Q25330, Q29S20, Q573E2, Q5NLF0, Q75EY3
Diamond homologs: Q17QP0, Q8CC14, Q8N7L0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
234 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:42786758:A:AG | acceptor_gain | 1.0000 |
| 13:42786758:AACAG:A | acceptor_gain | 1.0000 |
| 13:42786761:A:AG | acceptor_gain | 1.0000 |
| 13:42786761:AG:A | acceptor_gain | 1.0000 |
| 13:42786762:G:GG | acceptor_gain | 1.0000 |
| 13:42786762:GG:G | acceptor_gain | 1.0000 |
| 13:42786762:GGC:G | acceptor_gain | 1.0000 |
| 13:42786762:GGCC:G | acceptor_gain | 1.0000 |
| 13:42786762:GGCCC:G | acceptor_gain | 1.0000 |
| 13:42786879:GCTTG:G | donor_gain | 1.0000 |
| 13:42786880:CTTG:C | donor_gain | 1.0000 |
| 13:42786881:TTG:T | donor_gain | 1.0000 |
| 13:42786882:TG:T | donor_gain | 1.0000 |
| 13:42786883:GG:G | donor_gain | 1.0000 |
| 13:42786884:G:GA | donor_loss | 1.0000 |
| 13:42786884:G:GG | donor_gain | 1.0000 |
| 13:42786885:TAAG:T | donor_loss | 1.0000 |
| 13:42788590:GGCT:G | acceptor_gain | 1.0000 |
| 13:42781663:GG:G | donor_gain | 0.9900 |
| 13:42781664:GG:G | donor_gain | 0.9900 |
| 13:42784049:T:A | acceptor_gain | 0.9900 |
| 13:42786752:T:TA | acceptor_gain | 0.9900 |
| 13:42786759:A:G | acceptor_gain | 0.9900 |
| 13:42788585:CCCTA:C | acceptor_loss | 0.9900 |
| 13:42788586:CCTA:C | acceptor_loss | 0.9900 |
| 13:42788588:TAGGC:T | acceptor_loss | 0.9900 |
| 13:42788589:A:AG | acceptor_gain | 0.9900 |
| 13:42788590:G:GG | acceptor_gain | 0.9900 |
| 13:42781661:TAGGG:T | donor_loss | 0.9800 |
| 13:42781662:AGGGT:A | donor_loss | 0.9800 |
AlphaMissense
884 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:42786796:A:C | S45R | 0.919 |
| 13:42786798:C:A | S45R | 0.919 |
| 13:42786798:C:G | S45R | 0.919 |
| 13:42786780:A:C | Q39H | 0.887 |
| 13:42786780:A:T | Q39H | 0.887 |
| 13:42786831:G:C | W56C | 0.806 |
| 13:42786831:G:T | W56C | 0.806 |
| 13:42788591:G:T | G74V | 0.791 |
| 13:42786863:T:C | L67P | 0.790 |
| 13:42788611:G:C | A81P | 0.768 |
| 13:42786775:G:T | G38W | 0.753 |
| 13:42786804:G:A | M47I | 0.753 |
| 13:42786804:G:C | M47I | 0.753 |
| 13:42786804:G:T | M47I | 0.753 |
| 13:42786839:T:C | L59P | 0.739 |
| 13:42786775:G:A | G38R | 0.734 |
| 13:42786775:G:C | G38R | 0.734 |
| 13:42788600:C:T | T77I | 0.726 |
| 13:42788597:T:G | I76S | 0.721 |
| 13:42786779:A:T | Q39L | 0.718 |
| 13:42786811:T:G | Y50D | 0.709 |
| 13:42786883:G:C | G74R | 0.709 |
| 13:42786835:G:C | A58P | 0.708 |
| 13:42786767:T:A | L35H | 0.702 |
| 13:42788609:A:T | E80V | 0.701 |
| 13:42786797:G:T | S45I | 0.691 |
| 13:42786848:G:C | R62P | 0.688 |
| 13:42786779:A:C | Q39P | 0.686 |
| 13:42786850:T:G | Y63D | 0.673 |
| 13:42786863:T:A | L67H | 0.673 |
dbSNP variants (sampled 300 via entrez): RS1000265988 (13:42785775 AT>A,ATT), RS1000439110 (13:42792034 T>TGTGC), RS1000581931 (13:42779985 T>A), RS1000608217 (13:42786451 T>C), RS1000615988 (13:42780653 C>A), RS1001784220 (13:42786065 T>C), RS1001877905 (13:42788210 A>G), RS1002118042 (13:42787402 T>C,G), RS1002354852 (13:42781062 G>T), RS1002483478 (13:42791674 T>A), RS1002513124 (13:42791426 A>G), RS1003052035 (13:42784614 G>A), RS1003076079 (13:42784244 C>A,T), RS1003573949 (13:42783164 T>C), RS1003955774 (13:42789859 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006016_24 | Serum alkaline phosphatase levels | 4.000000e-21 |
| GCST009442_4 | Age-related cognitive decline (executive function) (slope of z-scores) | 4.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004533 | alkaline phosphatase measurement |
| EFO:0007710 | cognitive decline measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.